Neuravi said today that it raised $21 million in a Series B round for its Embotrap minimally invasive thrombectomy device. “The intention of the funding round is to launch the device in Europe, to run the Arise program for the U.S., to attempt to bring the device for U.S. approval and to continue to develop further […]